S.A. Martynchik1, S.V. Filatenkova2
1I.M. Sechenov First Moscow State Medical University, Moscow
2Polyclinic ¹6 at the Federal Security Service of Russia, Moscow
Summary. A brief review of the foreign and domestic
literature that had been devoted to evaluation of the social economic
burden associated with ischemic heart disease was compiled. Under this
burden a whole complex of factors was meant here, including social,
economic, and organizational ones. The latter implied a wide range of
problems including elevating medical access through organizational
measures, improving the quality of medical care, and enhancing
efficiency of budget funding.
Expediency of program-target approach to managing programs of funding
for acute coronary syndrome associated with high risk of instantaneous
death and fatal/non-fatal myocardial infarction was appreciated.
Adopted programmed measures for improving organizational patterns of
delivering medical care were investigated into, including wide
introduction of endovascular technologies of re-perfusion therapy and
measures of secondary prevention of ischemic heart disease following old
myocardial infarction. Optimization of operation of the facilities of
cardiac profile necessitates economic substantiation of technologies and
programs of budgeting, including creation of national hospital register
and introduction of the quality control system for providing medical
care on the basis of standards of medical care and target indicators.
Quality of medical care and medical access for the population were
studied in connection with the efficiency of budget expenditure for
medical facilities. Cost evaluation of expenditure per completed case of
medical care in coronary syndrome was performed. Efficacious means of
reimbursement for expenditure implying immediate and remote receipts
were assessed.
Economically expedient means of financial provision of the programs for
the improvement of methodological foundation of standardization of all
ways of expenditure was considered here, including development of
methodological foundation for such standardization, procedure of
planning with the use of enlarged volumes of medical care, grouping of
patients along the criteria of clinical and outlaying similarity,
establishment of standards of financial costs and differentiated tariffs
that would imply elevation to new therapeutic and diagnostic
highlights, predictability in fulfillment of programs and measures,
creation of certain stimuli for reducing expenditure and efficient
management of the materiel resources.
Keywords. Acute coronary syndrome; unstable angina pectoris;
myocardial infarction; hospital lethality; endovascular techniques of
diagnosis and treatment; thrombolytic therapy; hospital registers;
standardization of expenditure; clinical statistical groups; standards
of financial expenditure; means of prospective payment; programmed
budgeting aimed to result.
References
-
Akchurin R.S., Vasilyev V.P., Galyautdinov D.M., Korolev S.V., Lepilin
M.G., Partigulov S.A., Shiryayev A.A.. Sovremennaya khirurgiya
koronarnykh arteriy [The present-day surgery of coronal arteries]. Kardiologicheskiy vestnik 2010;(1):45-48.
-
Gratsianskiy N.A. K publikatsii obnovlennogo rukovodstva Yevropeyskogo
obshchestva kardiologov po lecheniyu ostrogo koronarnogo sindroma bez
podyemov segmenta ST na EKG [On publication of updated manual of the
European Cardiological Society on treatment of acute coronary syndrome
with no ST segment rising in ECG]. Kardiologiya 2007;(9):24-33.
-
Gratsianskiy N.A. Antitromboticheskoye lecheniye pri ostrom koronarnom
sindrome bez podyemov segmenta ST: sovremennoye sostoyaniye i nekotoryye
perspektivy [Anti-thrombosis treatment in acute coronary syndrome with
no ST segment rising: the current state and some prognosis]. Aterotromboz 2008;(1):4-21.
-
Savchenko A.P., Rudenko B.A. Klinicheskaya effektivnost
endovaskulyarnykh tekhnologiy pri lechenii ishemicheskoy bolezni serdtsa
[Clinical efficiency of endovascular methods in treatment of ischemic
heart diseases]. Kardiologicheskiy vestnik 2008;(1):5-11.
-
Timchinskiy D.L. Sovershenstvovaniye mekhanizmov oplaty statsionarnoy
pomoshchi kardiologicheskogo profilya i tarifnogo regulirovaniya v
usloviyakh dobrovolnogo meditsinskogo strakhovaniya [Improving payment
methods for inpatient cardiological care and tariff regulation in
voluntary health insurance]. [PhD. Thesis]. Moscow; 2010. 24 p.
-
Chazov Ye.I., Boytsov S.A. Okazaniye meditsinskoy pomoshchi bolnym s
ostrym koronarnym sindromom v ramkakh programmy sozdaniya regionalnykh i
pervichnykh sosudistykh tsentrov v Rossiyskoy Federatsii strane
[Delivery of medical care to patients with acute coronary syndrome
within the frames of the Program on development of regional and primary
vascular centers in the Russian Federation]. Kardiologicheskiy vestnik 2008;(2):5-11.
-
Chazov Ye.I., Boytsov S.A. Puti snizheniya serdechno-sosudistoy
smertnosti v strane [Ways of reducing cardiovascular mortality in the
country]. Kardiologicheskiy vestnik 2009;(1):5-10.
-
Shchetinkina I.N. Klinicheskaya i farmakoekonomicheskaya effektivnost
tromboliticheskoy terapii infarkta miokarda s podyemom ST v klinicheskoy
praktike [Clinical and pharmaeconomical efficiency of thrombolytic
therapy of myocardial infarction with ST rising in clinical practice]
[PhD. Thesis]. Saratov; 2009. 23 p.
-
Erlikh A.D., Gratsianskiy N.A. Lecheniye bolnykh ostrym koronarnym
sindromom s podyemom ST v statsionarakh imeyushchikh i ne imeyushchikh
vozmozhnosti vypolneniya koronarnykh vmeshatelstv (dannyye registra
«REKORD» [Treatment of acute coronary syndrome patients with ST rising
in hospitals having (having no) the capacity to perform coronary
interventions (by “RECORD” registration data]. Aterotromboz 2009;(1):120-122.
-
Andre E., Cordero A., Maga P., Alegrı E., Leo M., Luengo E., Botaya R,.
Ortiz L. J. Casasnovasd. Long-Term Mortality and Hospital Readmission
After Acute Myocardial Infarction: an Eight-Year Follow-Up Study. Rev.
Esp. Cardiol. 2011;(4):1–7.
-
Avxentieva M, Vorobjov P., Sura M. Cost of myocardial infarction
treatment in Russian Federation PCV38: Value in Health, Volume 7, Issue
6, November–December 2004, Pages 696-697.
-
Celik Turgay, Iyisoy Atila. Primary stenting in the patients with acute
myocardial infarction: The preferred strategy. Int. J. Cardiol.
2009;133:241–4.
-
Chen Chin-Shyan, Liu Tsai-Ching, Chiu Wen-Ta, Lin Herng-Ching. Impact
of hospital and physician characteristics on medical expenditures for
acute myocardial infarction hospitalization. International Journal of
Cardiology 2007;121:127–129.
-
Cox D.A., Cohen D. J. Cost Effectiveness of Paclitaxel-Eluting Stents
for Patients Undergoing Percutaneous Coronary Revascularization. Journal
of the American College of Cardiology 2006;48(2):253–61.
-
Epstein D.M., Sculpher M. J., Clayton T.C., Henderson R.A., Pocock
S.J., Buxton M.J., Fox K.A. Costs of an early intervention versus a
conservative strategy in acute coronary syndrome. International Journal
of Cardiology 2008;127:240–246.
-
Holmes D.R., Firth B.G., Wood D.L. Paradigm Shifts in Cardiovascular.
Medicine Journal of the American College of Cardiology
2004;43(4):507–12.
-
Lee V.W, Chan W.K., Lam N.L., Lee K.K. Evaluation on the cost of
management of acute myocardial infarction in a local public hospital in
Hong Kong. PCV44: Evaluation on the cost of management of acute
myocardial infarction in a local public hospital in Hong Kong. Value in
Health, Vol., Issue 3, May–June 2003, Page 323.
-
Lieu T.A., Gurley R.J., Lundstrom R. J., Ray G.T., Fireman B.H.,
Weinstein M.C., Parmley W.W. Projected Cost-Effectiveness of Primary
Angioplasty for Acute Myocardial Infarction. JACC 1997;30(7):1741–50.
-
López-Valcárcel B.G., Pinilla J. The Impact of Medical Technology on
Health: A Longitudinal Analysis of Ischemic Heart Disease. Value in
Health 2008; Vol. 11, Number 1, p.88-96
-
Mantovani L.G., Fornari C., Madotto F., Riva M. A, Merlino L., Ferrario
M.M., Chiodini V., Zocchetti A., Corrao G., Cesana G. Burden of acute
myocardial infarction. Curr. Med. Res. Opin 2008;24:461–8.
-
Myocardial Infarction Redefined - A Consensus Document of The Joint
European Society of Cardiology (American College of Cardiology Committee
for the Redefinition of Myocardial Infarction The Joint European Society
of Cardiology). American College of Cardiology Committee. Journal of
the American College of Cardiology 2000;36(3):959–69.
-
Salvo T.G. Di, Paul S.D., Lloyd-Jones D., J.Smith A., Levy G.V. Bamezal
V., Hussen S., Eagle K. A., O’Gara P. T. Care of Acute Myocardial
Infarction by Noninvasive and Invasive Cardiologists: Procedure Use,
Cost and Outcome. J. Am. CoLL. Cadiol. 1996;27:242–9.
-
Smolderen K.G., Bell A., Lei Y., Cohen E.A., Steg G. Bhatt D. L,
Mahoney E. M. One-year costs associated with cardiovascular disease in
Canada: Insights from the Reduction of Atherothrombosis for Continued
Health (REACH) registry for Continued Health (REACH) registry. Can J.
Cardiol. 2010;26(8):297–305.
-
Spertus J.I., Hlatky M., Martin J.S., Weaver W.D. Length of Hospital
Stay After Acute Myocardial Infarction in the Myocardial Infarction
Triage and Intervention (MITI) Project Registry. JACC 1996;28(2):287–93.
-
Steinberg E.P., Topol E.J., Sakin J.W., Kahane S.N., Apptel L.J., Powe
N.R., Anderson G.F., Erikson J.E., Guerci A.D. Cost and Procedure
Implications of Thrombolytic Therapy for Acute Myocardial Infarction. I.
Am. Coll. Cardiol. 1988;12:58A–68A.
-
Torti F.M, Shelby D.R., Kevin A.S. Analytic Considerations in Economic
Evaluations of Multinational Cardiovascular Clinical Trials. Value in
Health 2008; vol. 9, Number 1, 88-96.
-
Vaitkus P.T., Witmer W.T., Brandenburg R.G., Wells S.K., Zenhnacker
J.B. Economic Impact of Angioplasty Salvage Techniques, With an Emphasis
on Coronary Stents: A Method Incorporating Costs, Revenues, Clinical
Effectiveness and Payer Mix. J. Am. Coll. Cardiol. 1997;30:894–900.
-
Valensi P., Lorgisb L., Cottinb Y. Prevalence, incidence, predictive
factors and prognosis of silent myocardial infarction: A review of the
literature. Archives of Cardiovascular Disease 2011;104:178–188.
-
Vidovich M.I., Xu Y. Cost and length of hospitalization in Hispanic
patients with acute myocardial infarction in the United States. J.
Cardiol. 2009;131:149–50.
-
Wang O., Wang C., Bernheim S.M., Drye E., Krumholz H.M. Indentifying
value in acute myocardial infraction care: compraring hospitals on
medicare costs and mortality E1171. JACC 2011;57 April 5, Issue 14.
Views: 21957
|